There are four main types of molecules commonly administered in this type of cancer therapy: (1) selective ER modulators (SERMs), (2) selective ER degraders (SERDs), (3) aromatase inhibitors, and (4) agonists of the luteinizing hormone-releasing hormone (LHRH) [25]. Here, GNRH1 is linked to cancer.